Literature DB >> 22833819

Establishment of an orthotopic lung cancer model in nude mice and its evaluation by spiral CT.

Xiang Liu, Jun Liu, Yubao Guan, Huiling Li, Liyan Huang, Hailing Tang, Jianxing He.   

Abstract

OBJECTIVE: To establish a simple and highly efficient orthotopic animal model of lung cancer cell line A549 and evaluate the growth pattern of intrathoracic tumors by spiral CT.
METHODS: A549 cells (5×10(6) mL(-1)) were suspended and inoculated into the right lung of BALB/c nude mice via intrathoracic injection. Nude mice were scanned three times each week by spiral CT after inoculation of lung cancer cell line A549. The survival time and body weight of nude mice as well as tumor invasion and metastasis were examined. Tissue was collected for subsequent histological assay after autopsia of mice.
RESULTS: The tumor-forming rate of the orthotopic lung cancer model was 90%. The median survival time was 30.7 (range, 20-41) days. The incidence of tumor metastasis was 100%. The mean tumor diameter and the average CT value gradually increased in a time-dependent manner.
CONCLUSIONS: The method of establishing the orthotopic lung cancer model through transplanting A549 cells into the lung of nude mice is simple and highly successful. Spiral CT can be used to evaluate intrathoracic tumor growth in nude mice vividly and dynamically.

Entities:  

Keywords:  A549; Lung cancer; orthotopic lung cancer model; spiral CT

Year:  2012        PMID: 22833819      PMCID: PMC3378238          DOI: 10.3978/j.issn.2072-1439.2012.03.04

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  17 in total

1.  In vivo respiratory-gated micro-CT imaging in small-animal oncology models.

Authors:  Dawn Cavanaugh; Evan Johnson; Roger E Price; Jonathan Kurie; Elizabeth L Travis; Dianna D Cody
Journal:  Mol Imaging       Date:  2004-01       Impact factor: 4.488

2.  DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer.

Authors:  V Moncho-Amor; I Ibañez de Cáceres; E Bandres; B Martínez-Poveda; J L Orgaz; I Sánchez-Pérez; S Zazo; A Rovira; J Albanell; B Jiménez; F Rojo; C Belda-Iniesta; J García-Foncillas; R Perona
Journal:  Oncogene       Date:  2010-10-04       Impact factor: 9.867

3.  An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice.

Authors:  Xiwu Chen; Yan Su; Barbara Fingleton; Heath Acuff; Lynn M Matrisian; Roy Zent; Ambra Pozzi
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Development of an orthotopic transplantation model in nude mice that simulates the clinical features of human lung cancer.

Authors:  Yun Kang; Motoko Omura; Akiko Suzuki; Takashi Oka; Yoshihiro Nakagami; Chao Cheng; Yoji Nagashima; Tomio Inoue
Journal:  Cancer Sci       Date:  2006-10       Impact factor: 6.716

5.  Refinement of an orthotopic lung cancer model in the nude rat.

Authors:  T H March; P G Marron-Terada; S A Belinsky
Journal:  Vet Pathol       Date:  2001-09       Impact factor: 2.221

6.  Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.

Authors:  Amir Onn; Takeshi Isobe; Satoshi Itasaka; Wenjuan Wu; Michael S O'Reilly; Waun Ki Hong; Isaiah J Fidler; Roy S Herbst
Journal:  Clin Cancer Res       Date:  2003-11-15       Impact factor: 12.531

7.  Quantification of mouse pulmonary cancer models by microcomputed tomography imaging.

Authors:  Hiroshi Fushiki; Tomoko Kanoh-Azuma; Masahiro Katoh; Ken Kawabata; Jian Jiang; Nozomi Tsuchiya; Akio Satow; Yoshitaka Tamai; Yoshihiro Hayakawa
Journal:  Cancer Sci       Date:  2009-05-13       Impact factor: 6.716

8.  Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.

Authors:  Hisatsugu Goto; Seiji Yano; Helong Zhang; Yuka Matsumori; Hirohisa Ogawa; David C Blakey; Saburo Sone
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

9.  Development of a large animal model for lung tumors.

Authors:  Kamran Ahrar; David C Madoff; Sanjay Gupta; Michael J Wallace; Roger E Price; Kenneth C Wright
Journal:  J Vasc Interv Radiol       Date:  2002-09       Impact factor: 3.464

Review 10.  Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Authors:  Hannah K Weir; Michael J Thun; Benjamin F Hankey; Lynn A G Ries; Holly L Howe; Phyllis A Wingo; Ahmedin Jemal; Elizabeth Ward; Robert N Anderson; Brenda K Edwards
Journal:  J Natl Cancer Inst       Date:  2003-09-03       Impact factor: 13.506

View more
  14 in total

1.  Pre-clinical imaging for establishment and comparison of orthotopic non-small cell lung carcinoma: in search for models reflecting clinical scenarios.

Authors:  Rozina Aktar; Antje Dietrich; Falk Tillner; Shady Kotb; Steffen Löck; Henning Willers; Michael Baumann; Mechthild Krause; Rebecca Bütof
Journal:  Br J Radiol       Date:  2018-10-11       Impact factor: 3.039

2.  ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.

Authors:  Christopher G England; Dawei Jiang; Reinier Hernandez; Haiyan Sun; Hector F Valdovinos; Emily B Ehlerding; Jonathan W Engle; Yunan Yang; Peng Huang; Weibo Cai
Journal:  Mol Pharm       Date:  2017-09-06       Impact factor: 4.939

3.  An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients.

Authors:  Sanaz Taromi; Gian Kayser; Dominik von Elverfeldt; Wilfried Reichardt; Friederike Braun; Wolfgang A Weber; Robert Zeiser; Meike Burger
Journal:  Clin Exp Metastasis       Date:  2016-07-06       Impact factor: 5.150

4.  The efficacy of the inhalation of an aerosolized Group A streptococcal preparation in the treatment of lung cancer.

Authors:  Jun Liu; Xiang Liu; Fei Cui; Guoqin Chen; Yubao Guan; Jianxing He
Journal:  Chin J Cancer Res       Date:  2012-12       Impact factor: 5.087

5.  Utility and applications of orthotopic models of human non-small cell lung cancer (NSCLC) for the evaluation of novel and emerging cancer therapeutics.

Authors:  Verline Justilien; Alan P Fields
Journal:  Curr Protoc Pharmacol       Date:  2013-10-08

6.  Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.

Authors:  Panagiotis Papageorgis; Sait Ozturk; Arthur W Lambert; Christiana M Neophytou; Alexandros Tzatsos; Chen K Wong; Sam Thiagalingam; Andreas I Constantinou
Journal:  Breast Cancer Res       Date:  2015-07-25       Impact factor: 6.466

7.  By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.

Authors:  Zun-yi Zhang; Sheng-ling Fu; Su-qin Xu; Xiao Zhou; Xian-shen Liu; Yong-jian Xu; Jian-ping Zhao; Shuang Wei
Journal:  Oncotarget       Date:  2015-01-30

8.  Immunotoxin Therapy for Lung Cancer.

Authors:  Li-Yi Xie; Hai-Lan Piao; Min Fan; Zhen Zhang; Chen Wang; Darell D Bigner; Xu-Hui Bao
Journal:  Chin Med J (Engl)       Date:  2017-03-05       Impact factor: 2.628

9.  Establishment and evaluation of the VX2 orthotopic lung cancer rabbit model: a ultra-minimal invasive percutaneous puncture inoculation method.

Authors:  Lijuan Wang; Keke Che; Zhonghong Liu; Xianlong Huang; Shifeng Xiang; Fei Zhu; Yu Yu
Journal:  Korean J Physiol Pharmacol       Date:  2018-04-25       Impact factor: 2.016

10.  Synthesis, radiolabelling, and biological assessment of folic acid-conjugated G-3 99mTc-dendrimer as the breast cancer molecular imaging agent.

Authors:  Saedeh Zamani; Mehdi Shafeie-Ardestani; Ahmad Bitarafan-Rajabi; Ali Khalaj; Omid Sabzevari
Journal:  IET Nanobiotechnol       Date:  2020-09       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.